Back

Sequencing Data of North American SARS-CoV-2 Isolates Shows Widespread Complex Variants

Ford, C. T.; Scott, R.; Jacob Machado, D.; Janies, D.

2021-01-29 infectious diseases
10.1101/2021.01.27.21250648 medRxiv
Show abstract

Several new variants of the SARS-CoV-2 have been isolated in the United States, Mexico, and Canada. Many of the variants contain single variants of functional significance (e.g. S: N501Y increases transmissibility). To study the occurrence and co-circulation of these variants, we have developed an easy-to-use dashboard at janieslab.github.io/sars-cov-2. We created a multiple sequence alignment workflow and processing script to generate a variant dataset, which populates this dashboard. We then use the features of the dashboard, such as visualization of the single and complex nucleotide variants geospatially and in a color-coded matrix format. Users also interact with the dashboard to filter the underlying data to regions of interest and or variants of interest. The user can export reports based on the desired filters, which we intend to be used for regionally specific pandemic response. We find in Genbank, an isolate from Massachusetts containing [(S: Q677H), (ORF3a: Q57H), (M: A85S), (N: D377Y)] collected on September 11, 2020. Moreover, we find that many viral isolates bear a marker of increased transmissibility (S: N501Y) in linkage with at least one variant of concern isolated from Ohio also range across the Untied States and stretch from British Columbia, Canada to Mexico. When we analyze co-circulation of more complex variant constellations with (S: N501Y), we note that the Upper Midwest and Northeast United States contain these isolates. In summary, the viral variants that have raised concern in a few US States in recent reports are widespread. Based on the increase in the proportion of variant viruses being sampled and some empirical evidence in the United Kingdom, South Africa, and Ohio, these variants are likely to lead to increased transmission of SARS-CoV-2 across North America in the coming months.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
Emerging Infectious Diseases
105 papers in training set
Top 0.1%
7.8%
2
Access Microbiology
25 papers in training set
Top 0.1%
7.2%
3
Journal of Medical Virology
140 papers in training set
Top 0.2%
6.6%
4
PLOS ONE
5266 papers in training set
Top 31%
4.8%
5
Pathogens
56 papers in training set
Top 0.1%
4.0%
6
mSphere
302 papers in training set
Top 2%
3.2%
7
Open Forum Infectious Diseases
142 papers in training set
Top 0.9%
3.2%
8
Viruses
332 papers in training set
Top 2%
3.2%
9
The Journal of Infectious Diseases
202 papers in training set
Top 1%
3.1%
10
Virus Evolution
155 papers in training set
Top 0.6%
3.1%
11
Scientific Reports
3612 papers in training set
Top 38%
2.7%
12
Clinical Infectious Diseases
235 papers in training set
Top 1%
2.4%
50% of probability mass above
13
Frontiers in Virology
15 papers in training set
Top 0.1%
2.4%
14
Archives of Virology
15 papers in training set
Top 0.1%
2.4%
15
Cureus
68 papers in training set
Top 2%
2.1%
16
Frontiers in Cellular and Infection Microbiology
109 papers in training set
Top 1%
2.1%
17
Journal of Clinical Virology
63 papers in training set
Top 0.4%
1.7%
18
International Journal of Infectious Diseases
129 papers in training set
Top 2%
1.7%
19
Virus Research
37 papers in training set
Top 0.4%
1.7%
20
PeerJ
308 papers in training set
Top 6%
1.7%
21
BMC Infectious Diseases
133 papers in training set
Top 3%
1.7%
22
Vaccines
198 papers in training set
Top 2%
1.5%
23
PLOS Pathogens
820 papers in training set
Top 7%
1.4%
24
Infection, Genetics and Evolution
42 papers in training set
Top 0.6%
1.1%
25
Journal of Clinical Virology Plus
10 papers in training set
Top 0.1%
1.1%
26
Microbiology Spectrum
469 papers in training set
Top 9%
1.1%
27
Frontiers in Medicine
120 papers in training set
Top 3%
1.0%
28
Frontiers in Public Health
148 papers in training set
Top 6%
1.0%
29
Wellcome Open Research
67 papers in training set
Top 1%
0.9%
30
JAMA
18 papers in training set
Top 0.4%
0.8%